AMERIPRISE FINANCIAL INC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,591,036
-$17,798,239 QoQ
Shares Held
204,601
-14.7% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#72
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. ALNY ranks #15 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,591,036 | 204,601 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $79,389,275 | 239,941 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $72,029,126 | 181,137 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $103,000,824 | 225,879 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $63,147,000 | 193,649 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,468,900 | 109,136 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,136,854 | 128,073 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,909,582 | 137,838 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,911,760 | 238,320 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,101,650 | 194,725 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $72,287,706 | 377,659 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $125,068,018 | 706,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $118,776,697 | 625,338 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $40,699,013 | 203,170 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $11,258,667 | 47,375 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,915,730 | 9,571 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,529,235 | 10,485 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,065,943 | 12,652 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,126,023 | 12,537 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,022,909 | 10,714 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,604,154 | 56,655 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,972,102 | 49,381 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,425,596 | 41,745 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,014,046 | 27,569 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,710,895 | 25,055 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,496,360 | 13,747 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||